526445
INDRANIB
Start SIP
Invest Now
Start SIP in INDRANIB
Performance
- Low
- ₹8
- High
- ₹9
- 52 Week Low
- ₹8
- 52 Week High
- ₹30
- Open Price₹9
- Previous Close₹9
- Volume33,524
- 50 DMA₹11.06
- 100 DMA₹12.38
- 200 DMA₹15.81
Investment Returns
- Over 1 Month -24.53%
- Over 3 Month -47.3%
- Over 6 Month -40.26%
- Over 1 Year -69.03%
Smart Investing Starts Here Start SIP with Indrayani Biotech for Steady Growth!
Indrayani Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -5
- PEG Ratio
- 0
- Market Cap Cr
- 38
- P/B Ratio
- 0.5
- Average True Range
- 0.84
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.79
- RSI
- 26.98
- MFI
- 26.81
Indrayani Biotech Financials
Indrayani Biotech Technicals
EMA & SMA
Current Price
₹8.40
-0.18
(-2.1%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹9.67
- 50 Day
- ₹11.06
- 100 Day
- ₹12.38
- 200 Day
- ₹15.81
Resistance and Support
8.37
- R3 9.34
- R2 9.07
- R1 8.64
- S1 7.94
- S2 7.67
- S3 7.24
Indrayani Biotech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-12-11 | Quarterly Results | |
| 2025-08-30 | Others | Inter-alia, to consider 1. Notice of the 33rd AGM of the Company. 2. Appointment of Mr. Swaminathan & Mr. Singarababu Indirakumar as Whole-Time Director. 3. Other business matters. |
| 2025-08-14 | Quarterly Results | |
| 2025-06-12 | Audited Results | (Revised) |
| 2025-04-03 | Rights issue of Equity Shares |
Indrayani Biotech F&O
About Indrayani Biotech
- NSE Symbol
- INDRANIB
- BSE Symbol
- 526445
- Managing Director
- Mr. Kasiraman Sayee Sundar
- ISIN
- INE007C01021
Similar Stocks to Indrayani Biotech
Indrayani Biotech FAQs
Indrayani Biotech share price is ₹8 As on 08 February, 2026 | 13:58
The Market Cap of Indrayani Biotech is ₹38.3 Cr As on 08 February, 2026 | 13:58
The P/E ratio of Indrayani Biotech is -5 As on 08 February, 2026 | 13:58
The PB ratio of Indrayani Biotech is 0.5 As on 08 February, 2026 | 13:58
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.